Telmisartan Tab Hypertension

• Status: Completed
• Trial end date: 1969-12-31

Summary

To assess the efficacy of telmisartan in hypertensive patients with high cardiovascular risk

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Hydrochlorothiazide; Telmisartan; Telmisartan, hydrochlorothiazide drug combination